Geniculate Ganglionitis Drugs Market Size & Share, by Treatment (Drugs, Surgery); Drug Type (Anticonvulsant, Anti-inflammatory Drugs, Antiviral Drugs, Tricyclics, Pregabalin); Distribution Channel (Hospital, Pharmacies, Specialty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

Geniculate Ganglionitis Drugs Market size is anticipated to witness more than 5.1% CAGR during the forecast period i.e., between 2024-2036. Geniculate ganglionitis, also known as, Ramsay Hunt syndrome, or Hunt's neuralgia, is a neurological disorder caused by infection with the same virus which causes chickenpox. In this syndrome, the virus infects the facial nerve connected to the ear, which is why the syndrome is characterized by chronic pain in middle and inner ear. The growth of the market can be attributed to the rising cases of chickenpox and shingles, as this is the most common cause of geniculate ganglionitis. Before the mass vaccine drives for chickenpox were initiated, over 100 deaths and more than 4 million cases of chickenpox were reported every year. After the vaccine drives, since 1996, this has reduced significantly. As of 2019, less than 350,000 cases of chickenpox were reported worldwide. Moreover, the developing public healthcare infrastructure and high government expenditure for the development of new drugs is anticipated to significantly fuel the growth of the market.